Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-003551
Accepted
2022-12-16 00:15:38
Documents
1
Effectiveness Date
2022-12-15
Registration Form
F-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 599
  Complete submission text file 9999999995-22-003551.txt   1796
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-267648 | Film No.: 221466343
SIC: 2836 Biological Products, (No Diagnostic Substances)